PropertyValue
?:abstract
  • Researchers launched the American Society of Hematology Research Collaborative COVID-19 Registry for Hematology in April to gather real-time data on patients with hematologic malignancies who develop COVID-19. Now, an analysis of the data reveals that 33% of patients with blood cancers who were hospitalized for COVID-19 died. Risk factors included older age, forgoing intensive treatment, and poor prognosis before infection.
is ?:annotates of
?:journal
  • Cancer_Discov
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Survival Factors ID\'d for Patients with Blood Cancer + COVID-19
?:type
?:who_covidence_id
  • #975749
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/xgeukpi0>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/xgeukpi0>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all